PhAST
PhAST is an artificial intelligence company in Cambridge, United States, founded in 2017. It has raised $10.6M across 1 round.
The fastest FDA-cleared antimicrobial susceptibility test
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- phast.ai
- Total Funding
- $10.6M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
PhAST develops antimicrobial susceptibility testing based on imaging individual cells as they respond to an antibiotic. Its computer vision models assess those responses to determine susceptibility and resistance. The testing approach examines phenotypic responses, providing information about bacterial reactions to antibiotic exposure.
Summary
It lists 11–50 employees. It has raised $10.6M in total across 1 round. Investors include SV Investment and Labcorp Venture Fund.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/phast"><img src="https://indexed.vc/api/badge/company/phast" alt="PhAST on Indexed.vc" width="260" height="76" /></a>